. "9"^^ . . "Article 3(a) of Regulation (EC) No 469/2009 of the European Parliament and of the Council of 6 May 2009 concerning the supplementary protection certificate for medicinal products must be interpreted as meaning that, in order for an active ingredient to be regarded as 'protected by a basic patent in force' within the meaning of that provision, it is not necessary for the active ingredient to be identified in the claims of the patent by a structural formula. Where the active ingredient is covered by a functional formula in the claims of a patent issued by the European Patents Office, Article 3(a) of that regulation does not, in principle, preclude the grant of a supplementary protection certificate for that active ingredient, on condition that it is possible to reach the conclusion on the basis of those claims, interpreted inter alia in the light of the description of the invention, as required by Article 69 of the Convention on the Grant of European Patents and the Protocol on the interpretation of that provision, that the claims relate, implicitly but necessarily and specifically, to the active ingredient in question, which is a matter to be determined by the referring court."@en . . "469/2009; Regulation; Article; substance; active; definition; structural; functional; kret\u00E9ria; products; medicinal; for; certificate; protection; supplementary; Convention; Patent; European"@en . . "4" . . . . . "CZ - \u010Cesk\u00E1 republika" . . . . . "\u010Cl\u00E1nek 3 (a) na\u0159\u00EDzen\u00ED (ES) Evropsk\u00E9ho parlamentu a Rady \u010D. 469/2009 ze dne 6. kv\u011Btna 2009 o dodatkov\u00FDch ochrann\u00FDch osv\u011Bd\u010Den\u00ED pro l\u00E9\u010Div\u00E9 p\u0159\u00EDpravky mus\u00ED b\u00FDt vykl\u00E1d\u00E1n v tom smyslu, \u017Ee pro to, aby aktivn\u00ED slo\u017Eky, kter\u00E9 maj\u00ED b\u00FDt pova\u017Eov\u00E1ny jako %22chr\u00E1n\u011Bn\u00E9 platn\u00FDm z\u00E1kladn\u00EDm patentem 've smyslu tohoto ustanoven\u00ED, nen\u00ED nutn\u00E9 pro \u00FA\u010Dinn\u00E9 l\u00E1tky, kter\u00E9 maj\u00ED b\u00FDt ur\u010Deny v n\u00E1roc\u00EDch patentu o strukturn\u00EDm vzorci. Je-li aktivn\u00ED l\u00E1tka kryta funk\u010Dn\u00ED vzorce v n\u00E1roc\u00EDch patentu vydan\u00E9ho evropsk\u00FDch patent\u016F \u00FA\u0159adu, \u010Dl. 3 (a) tohoto na\u0159\u00EDzen\u00ED nen\u00ED v z\u00E1sad\u011B nebr\u00E1n\u00ED ud\u011Blen\u00ED dodatkov\u00E9ho ochrann\u00E9ho osv\u011Bd\u010Den\u00ED pro danou \u00FA\u010Dinnou l\u00E1tku, za p\u0159edpokladu, \u017Ee je mo\u017En\u00E9 dosp\u011Bt k z\u00E1v\u011Bru na z\u00E1klad\u011B t\u011Bchto n\u00E1rok\u016F, interpretov\u00E1ny mimo jin\u00E9 ve sv\u011Btle popisu vyn\u00E1lezu, jak je po\u017Eadov\u00E1no podle \u010Dl\u00E1nku 69 \u00FAmluvy o ud\u011Blov\u00E1n\u00ED evropsk\u00FDch patent\u016F a protokol o v\u00FDkladu tohoto ustanoven\u00ED, \u017Ee pohled\u00E1vky vztahuj\u00ED, konkludentn\u011B, ale nezbytn\u011B, a zejm\u00E9na, aby \u00FA\u010Dinn\u00E9 l\u00E1tky v ot\u00E1zce, kter\u00E1 je v\u011Bc, kterou ur\u010D\u00ED p\u0159edkl\u00E1daj\u00EDc\u00EDm soudem." . . "Ba\u017Eantov\u00E1, Ilona" . "Evropsk\u00E1 patentov\u00E1 \u00FAmluva a dodatkov\u00E9 ochrann\u00E9 osv\u011Bd\u010Den\u00ED pro l\u00E9\u010Div\u00E9 p\u0159\u00EDpravy; kret\u00E9ria a funk\u010Dn\u00ED a struktur\u00E1ln\u00ED definice \u00FA\u010Dinn\u00E9 l\u00E1tky [\u010Dl. 3 na\u0159\u00EDzen\u00ED (ES) \u010D. 469/2009]"@cs . "23" . . . . "Evropsk\u00E1 patentov\u00E1 \u00FAmluva a dodatkov\u00E9 ochrann\u00E9 osv\u011Bd\u010Den\u00ED pro l\u00E9\u010Div\u00E9 p\u0159\u00EDpravy; kret\u00E9ria a funk\u010Dn\u00ED a struktur\u00E1ln\u00ED definice \u00FA\u010Dinn\u00E9 l\u00E1tky [\u010Dl. 3 na\u0159\u00EDzen\u00ED (ES) \u010D. 469/2009]" . . . "[0C5807948BE4]" . . . "The European Patent Convention and the supplementary protection certificate for medicinal products; kret\u00E9ria a functional and structural definition of the active substance [Article 3 of Regulation (EC) No 469/2009]"@en . . . "RIV/00216208:11220/14:10218451" . "Evropsk\u00E1 patentov\u00E1 \u00FAmluva a dodatkov\u00E9 ochrann\u00E9 osv\u011Bd\u010Den\u00ED pro l\u00E9\u010Div\u00E9 p\u0159\u00EDpravy; kret\u00E9ria a funk\u010Dn\u00ED a struktur\u00E1ln\u00ED definice \u00FA\u010Dinn\u00E9 l\u00E1tky [\u010Dl. 3 na\u0159\u00EDzen\u00ED (ES) \u010D. 469/2009]"@cs . "Evropsk\u00E1 patentov\u00E1 \u00FAmluva a dodatkov\u00E9 ochrann\u00E9 osv\u011Bd\u010Den\u00ED pro l\u00E9\u010Div\u00E9 p\u0159\u00EDpravy; kret\u00E9ria a funk\u010Dn\u00ED a struktur\u00E1ln\u00ED definice \u00FA\u010Dinn\u00E9 l\u00E1tky [\u010Dl. 3 na\u0159\u00EDzen\u00ED (ES) \u010D. 469/2009]" . "11220" . . . "1210-8278" . . "RIV/00216208:11220/14:10218451!RIV15-MSM-11220___" . "1"^^ . . "Obchodn\u00ED pr\u00E1vo" . . "15617" . "I" . . . "The European Patent Convention and the supplementary protection certificate for medicinal products; kret\u00E9ria a functional and structural definition of the active substance [Article 3 of Regulation (EC) No 469/2009]"@en . "\u010Cl\u00E1nek 3 (a) na\u0159\u00EDzen\u00ED (ES) Evropsk\u00E9ho parlamentu a Rady \u010D. 469/2009 ze dne 6. kv\u011Btna 2009 o dodatkov\u00FDch ochrann\u00FDch osv\u011Bd\u010Den\u00ED pro l\u00E9\u010Div\u00E9 p\u0159\u00EDpravky mus\u00ED b\u00FDt vykl\u00E1d\u00E1n v tom smyslu, \u017Ee pro to, aby aktivn\u00ED slo\u017Eky, kter\u00E9 maj\u00ED b\u00FDt pova\u017Eov\u00E1ny jako %22chr\u00E1n\u011Bn\u00E9 platn\u00FDm z\u00E1kladn\u00EDm patentem 've smyslu tohoto ustanoven\u00ED, nen\u00ED nutn\u00E9 pro \u00FA\u010Dinn\u00E9 l\u00E1tky, kter\u00E9 maj\u00ED b\u00FDt ur\u010Deny v n\u00E1roc\u00EDch patentu o strukturn\u00EDm vzorci. Je-li aktivn\u00ED l\u00E1tka kryta funk\u010Dn\u00ED vzorce v n\u00E1roc\u00EDch patentu vydan\u00E9ho evropsk\u00FDch patent\u016F \u00FA\u0159adu, \u010Dl. 3 (a) tohoto na\u0159\u00EDzen\u00ED nen\u00ED v z\u00E1sad\u011B nebr\u00E1n\u00ED ud\u011Blen\u00ED dodatkov\u00E9ho ochrann\u00E9ho osv\u011Bd\u010Den\u00ED pro danou \u00FA\u010Dinnou l\u00E1tku, za p\u0159edpokladu, \u017Ee je mo\u017En\u00E9 dosp\u011Bt k z\u00E1v\u011Bru na z\u00E1klad\u011B t\u011Bchto n\u00E1rok\u016F, interpretov\u00E1ny mimo jin\u00E9 ve sv\u011Btle popisu vyn\u00E1lezu, jak je po\u017Eadov\u00E1no podle \u010Dl\u00E1nku 69 \u00FAmluvy o ud\u011Blov\u00E1n\u00ED evropsk\u00FDch patent\u016F a protokol o v\u00FDkladu tohoto ustanoven\u00ED, \u017Ee pohled\u00E1vky vztahuj\u00ED, konkludentn\u011B, ale nezbytn\u011B, a zejm\u00E9na, aby \u00FA\u010Dinn\u00E9 l\u00E1tky v ot\u00E1zce, kter\u00E1 je v\u011Bc, kterou ur\u010D\u00ED p\u0159edkl\u00E1daj\u00EDc\u00EDm soudem."@cs . "1"^^ .